Introduction
============

The human body continuously repairs damaged tissues and opposes senescence-related processes due to the peculiar properties of its resident stem cells. Human mesenchymal stem cells (hMSCs) in fact are able of self-renewal and multi-lineage differentiation and the equilibrium between these two events determines the stem cell fate and their roles in the human body [@B1]. They can be isolated and expanded *in vitro* from virtually all adult tissues [@B2], including bone marrow [@B3], adipose tissue [@B4], peripheral blood [@B3], and also from several fetal and perinatal sources, as well as placenta [@B5], umbilical cord [@B6] and cord blood [@B7]. MSCs obtained from various sources differ in their biological characteristics [@B8],[@B9], and their proteome and transcriptome profiles revealed source specific markers [@B10]. Moreover, diversity in multi-lineage differentiation potency and paracrine functions [@B8],[@B9],[@B11],[@B12] determine different clinical applications of hMSCs [@B13]. Recently, hMSCs have been utilized for cell-based therapy in regenerative medicine to treat several injury and degenerative disorders, like Crohn\'s disease, diabetes mellitus, multiple sclerosis, myocardial infarction, liver failure, and rejection after liver transplant [@B14]-[@B21].

Since cell-based therapy procedures usually require hundreds of million hMSCs for each treatment (<http://www.clinicaltrials.gov>), cells isolated from donors need to be expanded *ex vivo* for several culture passages to obtain a large amount of cells prior to transplantation [@B13],[@B22].

Unfortunately, as the function of hMSCs decreases with age *in vivo* [@B23],[@B24], hMSCs, as well as all cultured primary cells [@B25], undergo cellular senescence along culture passages, with substantial decay in differentiation and self-renewal potential [@B22]-[@B24]. Premature senescence is a continuous process where cells share many molecular and functional characteristics, including changes in morphology, enhanced Senescence-Associated β-Galactosidase (SA β-Gal) activity, and permanent cell cycle arrest [@B22],[@B26].

Oxidative stress, defined as an imbalance between the production of free radicals/Reactive Oxygen Species (ROS), and antioxidants [@B27], is thought to contribute significantly to DNA damage and cellular senescence [@B28]-[@B30]. According to the free radical or oxidative stress theory of aging [@B31], oxidative stress incurs when the cellular antioxidant defense systems fail to counteract ROS bringing them back to their basal levels.

For this reason, hydrogen peroxide (H~2~O~2~) treatment is commonly used as a model for assessing cellular susceptibility to oxidative stress*.* Although hMSCs appear to efficiently handle oxidative stress, nevertheless they undergo premature senescence*in vitro* when exposed to H~2~O~2~ [@B32],[@B33]. Understanding hMSC behavior in oxidative stress would be important to study how to postpone, anticipate or revert Oxidative Stress-Induced Premature Senescence (OSIPS) in hMSC cultures.

It has been recently shown that OSIPS is a common feature in bone marrow hMSCs, the stem cell population that has been first isolated and characterized, with evidence ranging from morphological traits and SA β-Gal positivity to differential proteomic/metabolomic signatures in H~2~O~2~ exposed cells, as compared with untreated controls [@B34]-[@B37]. In hMSCs isolated from adipose tissue (hASCs), H~2~O~2~ was found to increase intracellular ROS production and to reduce antioxidant defenses (*i.e.* superoxide dismutase - SOD and glutathione synthetase - GSH) [@B38], hampering cell viability in a dose- and exposure time- dependent manner [@B38],[@B39]. It has been recently shown that SOD2 overexpression in ASCs promotes cell resistance to oxidative stress [@B40]. Moreover, H~2~O~2~ treatment provokes DNA breaks [@B41], raises SA β-Gal positive cells [@B42], alters the expression of senescent marker genes, as well as *p53*, *p21*, *mitogen-activated protein kinase 14* (*MAPK14*, alias *p38*) and *sirtuin 1* (*SIRT1*) [@B38],[@B39],[@B42], and increases apoptosis with a decline of pro-survival gene expression [@B38]. It has been recently shown that also human Wharton\'s Jelly-derived MSCs (hWJ-MSCs) treated with H~2~O~2~ undergo premature senescence at early culture passages: these cells show typical changes in morphology [@B43], slow their proliferation [@B44],[@B45], result positive for SA β-Gal [@B43],[@B44], express typical senescence [@B43] and pro-apoptotic gene markers, while displaying a down-regulation of survival genes [@B44],[@B46].

The aim of the present study was to investigate and compare the effects of H~2~O~2~ on morphology, proliferation and senescence in hASCs and hWJ-MSCs, as representative of adult and perinatal tissues derived hMSCs, respectively. In particular, we investigated along time the effects of H~2~O~2~ supplied to hMSCs at different concentrations (ranging from 50 to 400 μM), for 1 or 2 hours (h), at low and high subculture passages.

The hASCs are commonly used in cell-based therapy since their isolation is minimally invasive and because they are abundant and rapid in proliferation. On the other hand, in the human body, these cells, as well as all other adult MSCs, exhibit an age-dependent decline in their repairing capacity, increasing their susceptibility to degenerative diseases, cell death and senescence processes. In fact, multiple studies showed that the age of tissue donors affects several properties of the cells [@B47]-[@B49]. In particular, aged hASCs are significantly compromised in their ability to support the vascular network formation, owing to alterations in angiogenic properties [@B50], and their genes, normally related to senescence, act as positive regulators of apoptosis [@B51].

On the other hand, neonatal MSCs such as hWJ-MSCs, in their short prenatal life are not so influenced by age [@B52],[@B53]. These cells express mesenchymal but not endothelial and hematopoietic markers [@B54],[@B55] and display several features of embryonic stem cells (ESCs) although with a minor expression of pluripotency genes [@B56]-[@B58], explaining the lack of tumorigenicity of hWJ-MSCs [@B59],[@B60].

The high efficiency of hWJ-MSC recovery compared with hASCs (1 to 5 × 10^4^ cells/cm of umbilical cord, while 1 g of adipose tissue yields approximately 5 × 10^3^ stem cells) [@B61],[@B62], the minimal ethical concerns associated with their use, their ability to modulate immunological responses and the fact that they are from young donors make them an ideal source of MSCs for therapeutic applications in allogeneic settings. Moreover, hWJ-MSCs are preferable to other stem cells isolated from perinatal tissues (*i.e.* fetal membranes) because their isolation guarantees the absence of contaminating maternal cells [@B52].

Therefore, the comparison between the hASC and hWJ-MSC response to oxidative stress can be useful to study the biological mechanisms at the basis of hMSC senescence and could provide two OSIPS models amenable to test putative anti-senescence modulators and develop anti-senescence strategies.

Materials and Methods
=====================

A comprehensive overview of the experimental procedures that have been used in this study was described in Figure [1](#F1){ref-type="fig"}.

hASCs and hWJ-MSCs: harvesting and culture
------------------------------------------

All tissue samples were obtained from subjects that gave their informed consent for inclusion before they participated in the study. The study was conducted in accordance with the Declaration of Helsinki, and the protocol was approved by the local Ethical Committees (CE) (S.Orsola-Malpighi University Hospital - project identification code: n.1645/2014, ref. 35/2014/U/Tess and Villalba Hospital - project identification code: 16076 of Bologna, Italy). hASCs have been isolated by Lipogems device (PCT/IB2011/052204) and characterized according to standard procedures and with ethical clearance, as previously described [@B63]. hASCs were cultured in alfa-Minimal Essential Medium (α-MEM, Carlo Erba Reagents, Milano, Italy) supplemented with 10% heat-inactivated Fetal Bovine Serum (FBS) (Gibco, Waltham, MA, USA), 1% Penicillin-Streptomycin Solution, 1% L-Glutamine 200 mM (Carlo Erba Reagents) [@B64]. hWJ-MSCs have been isolated from umbilical cords from healthy donor mothers and characterized as previously described [@B65],[@B66]; cells were cultured in Dulbecco\'s Modified Eagle\'s Medium (DMEM) low glucose (BioWhittaker Cambrex, Walkersville, MD, USA) supplemented with 10% FBS (Gibco) and 1% Penicillin-Streptomycin Solution. Both hASCs and hWJ-MSCs were maintained at standard culture conditions of 37°C with 5% carbon dioxide in a humidified atmosphere. The non-adherent cells were removed, medium was changed twice a week and at 80% confluency cells were detached by treatment with trypsin-EDTA (Sigma-Aldrich Co., St. Louis, MO, USA), maintained and expanded until desired experimental culture passages. Both hASCs and hWJ-MSCs were derived from four healthy donors.

Hydrogen peroxide treatment
---------------------------

In order to test hydrogen peroxide (H~2~O~2~, Sigma-Aldrich Co.) capacity to induce cell senescence, hASCs and hWJ-MSCs were treated with different H~2~O~2~ concentrations and then submitted to a Resazurin-based proliferation (Sigma-Aldrich Co.) or to a SA β-Gal (Sigma Aldrich Co.) assays. Cells were incubated at 37°C in complete cell culture medium containing H~2~O~2~ for 1 or 2 h. Untreated cells were considered as controls. In preliminary experiments, cells to be used for the cell counts and proliferation assay were exposed to five H~2~O~2~ concentrations (50, 100, 150, 200 or 400 μM), while cells to be used for SA β-Gal assay, were treated with the same H~2~O~2~ concentrations, except for the 50 μM. In the following experiment settings, H~2~O~2~ 400 μM was excluded. Moreover, a gene expression analysis was performed after 48 h from the end of the H~2~O~2~ *stimulus*: hASCs and hWJ-MSCs were treated for 2 h with H~2~O~2~ 150 or 200 μM respectively.

Cell count
----------

hASCs and hWJ-MSCs, both obtained from one healthy subject (subculture passages 9^th^ and 8^th^, respectively), were used in three different experiments: they were seeded in 24-well plates at the density of 4000 and 3500 cells/cm^2^, respectively. After 24 h in standard conditions, cells were exposed for 2 h at H~2~O~2~ 50, 100, 150, 200 and 400 μM or unexposed (control cells) in technical duplicate. At the end of the treatment, fresh medium was added in all the wells and culture plates were incubated in standard conditions until the count test. At 24, 48 and 72 h from the end of the *stimulus*, cells were detached by trypsin-EDTA and resuspended in a medium with 50% Eritrosyn B dye 0.2% in PBS (Sigma-Aldrich); counts were done under a light microscope at least twice with a Neubauer chamber (BRAND GmbH, Wertheim, Germany) and the cell number was calculated following the manufacturer\'s specifications.

Cell metabolic activity and proliferation
-----------------------------------------

To evaluate the proliferation as function of metabolic activity of the cells, the "*In vitro* toxicology assay kit - Resazurin based" (Sigma-Aldrich Co.) was used. In this assay, metabolically active cells reduce Resazurin (not-fluorescent and blue) to Resorufin (highly fluorescent and red). Resorufin is a water-soluble compound and its intrinsic fluorescence can be measured avoiding the cell lysis (necessary with tetrazolium-salt based assays, *i.e.* MTT test). This allows to monitor cell proliferation of the same sample over time [@B67]. A preliminary proliferation study was conducted in order to determine the hASC and hWJ-MSC adequate cell density for seeding (data not shown). On the basis of results, hASCs and hWJ-MSCs were seeded in quadruplicates in a 96-well plate (BD Biosciences, Milano, Italy) at 4000 cells/cm^2^ or 3500 cells/cm^2^ respectively, in each experiment.

To determine the hASC and hWJ-MSC growth curves and to compare their basal proliferation, both hASCs and hWJ-MSCs were recovered from 4 healthy subjects (passages of subculture spanning from 6^th^ to 14^th^ and from 6^th^ to 16^th^, respectively). Then, in order to preliminarily evaluate the toxicity of H~2~O~2~ treatment, both hASCs and hWJ-MSCs (9^th^ and 8^th^ subculture passage, respectively) were obtained from one subject and cells were treated in a technical quadruplicate with H~2~O~2~ at 5 different concentrations (50, 100, 150, 200 and 400 μM) for 1 and 2 h. Later, in order to evaluate the effect of selected H~2~O~2~ concentrations on hASC and on hWJ-MSC proliferation, experiments (in technical quadruplicate) were performed with cells obtained from 4 healthy subjects (passages of subculture spanning from 6^th^ to 14^th^ and from 6^th^ to 16^th^, respectively). Finally, to perform a comparative analysis of cell proliferation throughout four different culture passages in hASCs (6^th^, 9^th^, 11^th^ and 14^th^) and in hWJ-MSCs (6^th^, 8^th^, 11^th^ and 16^th^), three different experiments were performed with cells derived from the same subject at each studied culture passage.

In every experimental test, after 24 h from the cell seeding in standard conditions, treated cells were exposed to H~2~O~2~ as described above and control cells were cultured in complete medium. At the end of treatment time, fresh complete medium with Resazurin reagent (at the ratio of 10:1 respectively) was added to each well and cells were incubated at 37°C. As a negative control Resazurin solution was added to the medium without cells; we also included the totally reduced Resazurin to the medium without cells as a positive control. The fluorescence signal was measured with the Wallac 1420 Victor2 Multilabel Counter (Perkin Elmer, Waltham, MA, USA) at wavelength of 590 nm using an excitation wavelength of 560 nm. Fluorescence was measured after 2, 4, 24, 48 and 72 h from the end of the treatment. The number of viable cells correlating with the magnitude of dye reduction was expressed as percentage of Resazurin reduction according to this formula: (FI 590 of test agent - FI 590 of negative control)/(FI 590 of 100% reduced of Resazurin - FI 590 negative control) × 100 where FI is Fluorescence Intensity.

Senescence-Associated β-Galactosidase assay
-------------------------------------------

To evaluate the SA β-Gal activity, the \"Senescence Cells Histochemical Staining Kit\" (Sigma-Aldrich Co.) was used. hASCs and hWJ-MSCs were seeded in 24-well plates (BD Biosciences) at the density of 4000 and 3400 cells/well, respectively. These specific cell densities were determined after a preliminary growth curve analysis (data not shown). After 24 h in standard conditions, cells were exposed to H~2~O~2~ as described above. A preliminary study was performed in triplicate for each treatment on hASCs and hWJ-MSCs derived from one subject (9^th^ and 8^th^ culture passage, respectively), and SA β-Gal assay was carried out after 24, 48 or 72 h from the end of the exposure to H~2~O~2~. Then SA β-Gal staining was investigated at 48 h using cells from three different subjects (n=3, culture passages ranging from 6^th^ and 9^th^) for each cell type. The assessment of SA β-Gal activity was carried out according to the manufacturer\'s instructions and the positive blue staining was used as a biomarker of cellular senescence. The number of positive (blue) and negative (not colored) cells was counted in each sample in at least three random fields under a light microscope (at 200× magnification and bright field illumination) [@B68]. To avoid staining due to cell confluence rather than to proliferative senescence, assay was performed in sub-confluent cultures displaying comparable cell density.

Capacity of cells to undergo passages post H~2~O~2~ treatments
--------------------------------------------------------------

In order to test the remaining adhesion cell capacity after H~2~O~2~ treatment, when cultures reached 80% confluency, cells were re-seeded in 24-well plates (BD Biosciences). Control cells were splitted with 1:3 ratio, while H~2~O~2~-treated cells were seeded with 1:1 ratio. Cells were analyzed the following days in order to identify the proliferation cell capacity and the complete growth arrest.

Morphological analysis of senescent H~2~O~2~-treated cells
----------------------------------------------------------

Cells were analyzed for morphological characteristics and changes under a light microscope (at 40× and 200× magnification) before treatment with H~2~O~2~, after 1 o 2 h of exposure, after 48 h from the end of the treatment and after their re-seeding. Cell images were detected under bright field illumination with the Leica MC170 HD Imaging System.

RNA extraction and RT-PCR
-------------------------

Cells obtained from one individual healthy subject for hASCs or hWJ-MSCs were seeded in T75 flasks at the density of 3500 cells/cm^2^. After 24 h in standard conditions, cells were exposed to H~2~O~2~ 150 μM (hASCs) or 200 μM (hWJ-MSCs) for 2 h. After 48 h from the end of the *stimulus*, total RNA was extracted from treated or untreated hMSCs using the RNeasy Mini Kit (QIAGEN, Valencia, CA, USA) and digested with RNase-free Deoxyribonuclease I (DNase I) (RNase-free DNase set, QIAGEN) following the manufacturer\'s instructions. RNAs were reverse-transcribed as previously described [@B69], except for the temperature of the reaction that was 37°C instead of 42°C. The success of the reaction was verified with *glyceraldehyde 3-phosphate dehydrogenase* (*GAPDH*) gene amplification as described in [@B70], except for 25 cycles instead of 45; *GAPDH* amplicon detection was performed by gel agarose electrophoresis, as described by Beraudi and coll. [@B71]. The experiment was repeated three times.

Real time PCR
-------------

For each experimental condition, 25 ng of cDNA were amplified using the SsoAdvanced Universal SYBR Green Supermix (Bio-Rad Laboratories, Hercules, CA, USA) in technical triplicates in a Bio-Rad CFX96 real-time thermal cycler (Bio-Rad Laboratories), as previously described [@B70]. Specific primers for *p53* and *p21* genes were designed by Bio-Rad and used following the manufacturer\'s instructions (*TP53* and *CDKN1A*, 20×, Bio-Rad Laboratories). Relative gene expression was determined by CFX Manager Software version 3.1 (Bio-Rad Laboratories) using *hypoxanthine phosphoribosyl transferase 1* (*HPRT1*), *TATA box binding protein* (*TBP*), *GAPDH* (20×, Bio-Rad Laboratories) as reference genes with the "delta-delta CT method"[@B72],[@B73].

Statistical analysis
--------------------

Data obtained from the *in vitro* toxicology assay were analyzed using one-way ANOVA followed by the Tukey HSD and Student\'s T-test. Data obtained from cell count assay were analyzed using one-way ANOVA followed by the Tukey HSD. Data obtained from real time PCR were analyzed by the CFX Manager Software version 3.1 (Bio-Rad Laboratories). Results were considered statistically significant with a p-value \< 0.05 and highly significant with a p-value \< 0.01.

Results
=======

Basal cell proliferation and senescence: a comparison between human ASCs and WJ-MSCs
------------------------------------------------------------------------------------

As previously described, the Resazurin-based assay allowed a cell proliferation monitoring over- and real- time, due to the Resorufin atoxicity [@B67]. On the basis of preliminary evaluations on hASC and hWJ-MSC growth curves (data not shown), cells were seeded at different concentrations (4000 cells/cm^2^ and 3500 cells/cm^2^, respectively) to perform proliferation experiments. In order to compare the cell metabolism of hASCs and hWJ-MSCs, results were expressed as growth rates, calculated as the percentage of Resazurin reduction at each time point divided by the percentage of reduction at the 2 h from the Resazurin inoculation. As shown in Figure [2](#F2){ref-type="fig"}A, the hWJ-MSC growth rate was significantly greater (at 48 h and 72 h time points, p\<0.05) than the one detected for hASCs (approximately twice). Cells derived from four subjects were used in each experiment for both hASCs and hWJ-MSCs related assays (passages of subculture spanning from 6^th^ to 14^th^ and from 6^th^ to 16^th^, respectively). Since basal metabolism was higher in hWJ-MSCs than in hASCs, in the following experiments we decided to analyze hASC and hWJ-MSC proliferation starting from 4 and 2 h from Resazurin administration, respectively. hMSC senescence in basal conditions was evaluated by SA β-Gal assay. Figure [2](#F2){ref-type="fig"}B shows the characteristic fibroblast-like morphology of both hASCs and hWJ-MSCs, cultured at the 9^th^ and the 8^th^ passage, respectively. After SA β-Gal staining, in both cell types only a small percentage of blue colored cells were appreciable (Figure [2](#F2){ref-type="fig"}C, black arrows).

Preliminary screening of H~2~O~2~ treated cells: proliferation analysis
-----------------------------------------------------------------------

hASCs and hWJ-MSCs cell count was performed after 24, 48 and 72 h from the end of H~2~O~2~ treatment (50, 100, 150, 200 and 400 μM) for 2h. Data shown in Figure [3](#F3){ref-type="fig"} (Panels A and B) were expressed as growth rates, calculated as the cell number at each time point divided by the cell number of seeded cells. Results underline that, in each experimental point, both hASCs and hWJ-MSCs treated with H~2~O~2~ were less in number comparing with untreated cells in a dose-dependent manner.

Moreover, a preliminary Resazurin based assay was performed to evaluate the toxicity of H~2~O~2~ on hASCs and hWJ-MSCs proliferation (derived from one subject at 9^th^ and 8^th^ subculture passage, respectively). The assay was performed after treatment with H~2~O~2~ at 5 different concentrations (50, 100, 150, 200 and 400 μM) for 1 and 2 h. In Figure [3](#F3){ref-type="fig"} (Panels C and D) we show the percentage of Resazurin reduction in presence or absence of a 2-h H~2~O~2~ treatment until 72 h post-treatment, expressed as the mean of technical quadruplicates. H~2~O~2~ treatment at 50, 100, 150 and 200 μM seems to act in a dose-dependent manner on cell metabolic activity in both the hMSC types, while 400 μM H~2~O~2~ induced an evident cell proliferation arrest in hASCs (Figure [3](#F3){ref-type="fig"}C). Similar results were obtained when H~2~O~2~ was administered for 1 h (data not shown).

In order to compare hASCs and hWJ-MSCs behavior, we decided to exclude the 400 μM higher concentration from the subsequent experimental plan.

Effect of H~2~O~2~ on hASC proliferation
----------------------------------------

We analyzed hASC proliferation up to 72 h following the termination of 1- or 2-h treatment in the presence of H~2~O~2~ at concentrations ranging from 50 to 200 μM. Cells were obtained from four healthy subjects (passages of subculture spanning from 6^th^ to 14^th^). We observed a decrease in the percentage of Resazurin reduction in H~2~O~2~-treated cells compared with untreated cells (Figure [4](#F4){ref-type="fig"}). After 1 h of H~2~O~2~ treatment (Figure [4](#F4){ref-type="fig"}, light grey lines), the differences between treated and untreated (control) cells were statistically significant (p\<0.05) at 48 h when treatment was in the presence of 150 μM H~2~O~2~ (Figure [4](#F4){ref-type="fig"}C), or at both 48 and 72 h when 200 μM H~2~O~2~ was used (Figure [4](#F4){ref-type="fig"}D). Cell exposure to H~2~O~2~ for 2 h (Figure [4](#F4){ref-type="fig"}, dark grey lines), further enhanced the significance of experimental outcomes. In particular, while among the lower concentrations (50 and 100 μM), 100 μM H~2~O~2~ affected proliferation (p\<0.05) after 24 h (Figure [4](#F4){ref-type="fig"}A and [4](#F4){ref-type="fig"}B), a 2-h treatment with higher concentrations (150 and 200 μM) of H~2~O~2~ significantly decreased cell proliferation at multiple time points: after 24 (p\<0.01) and 48 (p\<0.05) h from the treatment with both 150 μM and 200 μM H~2~O~2~, and even after 72 h (p\<0.05) in cells exposed to this latter concentration (Figure [4](#F4){ref-type="fig"}C and [4](#F4){ref-type="fig"}D).

Since the presence of 200 μM H~2~O~2~ for 2-h treatment induced in hASCs the most evident reduction of cell proliferation, we also decided to perform comparative analysis of cell proliferation throughout four different culture passages (p6, p9, p11 and p14), in which these cells may intrinsically differ in senescence susceptibility, following a 2-h treatment in the presence of 200 μM H~2~O~2~. As shown in Figure [5](#F5){ref-type="fig"}, we observed that, irrespective of the time spent in culture at different passages, H~2~O~2~-exposed hASCs shared a similar proliferation decrease in comparison with the related control cells.

Effect of H~2~O~2~ on hWJ-MSC proliferation
-------------------------------------------

In Figure [6](#F6){ref-type="fig"}, we show the proliferation curves of hWJ-MSCs treated for 1 and 2 h with H~2~O~2~ at concentrations ranging from 50 to 200 μM. Cells were obtained from four healthy subjects (passages of subculture spanning from 6^th^ to 16^th^). H~2~O~2~ at 50, 100 and 150 μM had a weak effect on hWJ-MSCs (Figure [6](#F6){ref-type="fig"}A, 6B and 6C), while a 2-h exposure to the higher concentration of H~2~O~2~ (200 μM) resulted in a significant decrease in the percentage of Resazurin reduction, as compared with control cells. This was evident at 24, 48 and 72 h following termination of the H~2~O~2~ treatment (p\<0.05) (Figure [6](#F6){ref-type="fig"}D).

As for hASCs, we analyzed cell proliferation in hWJ-MSCs throughout four distinct subculture passages (p6, p8, p11 and p16): it was evident that exposed and unexposed cells exhibited a differential response as a function of the time spent in culture (Figure [7](#F7){ref-type="fig"}). In fact, in early passages (*i.e.* p6) proliferation was not affected from the treatment at any time point. In contrast, in late passages (*i.e.* p11 and p16) proliferation always decreased in treated cells compared with control cells (Figure [7](#F7){ref-type="fig"}).

Effect of H~2~O~2~ on hASC SA β-Galactosidase activity
------------------------------------------------------

We first evaluated the H~2~O~2~ effect on SA β-Gal activity in hASCs (at subculture passage 9^th^) recovered from one healthy subject (in technical triplicate). H~2~O~2~ was used at the final concentrations of 100, 150, 200 and 400 μM for 1 and 2 h, and the assay was performed after 24, 48 and 72 h from the termination of the *stimuli*. At each experimental time point, 400 μM H~2~O~2~ produced a toxic effect and for this reason such a high concentration was not used for the assessment of SA β-Gal expression (data not shown). In all investigated conditions, H~2~O~2~ increased the enzyme activity in comparison with the related controls (considered as a value of 1) (Figure [8](#F8){ref-type="fig"}A and Figure [8](#F8){ref-type="fig"}B). We arbitrarily defined a ratio greater than 3 in the percentage of blue cells in treated versus control hASCs as a proof for the effectiveness of the treatment. Under these experimental conditions, after 1 h of exposure only 150 or 200 μM H~2~O~2~ raised SA β-Gal staining at 48 h from the termination of the treatment (Figure [7](#F7){ref-type="fig"}A). On the contrary, after a 2-h treatment all the H~2~O~2~ concentrations tested efficaciously increased SA β-Gal activity at 48 h from the end of treatment, with a more prolonged effect lasting up to 72 h when a concentration of 200 μM H~2~O~2~ was used (Figure [7](#F7){ref-type="fig"}B).

After a critical analysis of this preliminary test, we further explored SA β-Gal activity after 48 h from the end of H~2~O~2~ treatment in cells that had been recovered from three healthy subjects (at subculture passages 6^th^-9^th^): in Figure [8](#F8){ref-type="fig"} we also show results from a representative experiment (Figure [8](#F8){ref-type="fig"}C) and the corresponding culture images of H~2~O~2~ 2-h exposure (Figure [8](#F8){ref-type="fig"}D). We found that the percentage of blue cells after each treatment was greater than in controls (Figure [8](#F8){ref-type="fig"}C) and that it reached a peak after the H~2~O~2~ 150 μM treatment.

Effect of H~2~O~2~ on hWJ-MSCs SA β-Galactosidase activity
----------------------------------------------------------

A preliminary SA β-Gal activity assay was performed in technical triplicate also on hWJ-MSCs (recovered from one healthy subject and at subculture passage 8^th^) after 24, 48 and 72 h from termination of the H~2~O~2~ treatment at concentrations of 100, 150, 200 and 400 μM for 1 and 2 h. As seen for hASCs, cells treated with H~2~O~2~ 400 μM were not analyzed due to the cytotoxicity of the treatment (data not shown).

In all experimental conditions, H~2~O~2~ treatments (as compared with controls, corresponding to a value 1) increased the enzyme activity, and consequently the percentage of blue stained senescent cells (Figure [9](#F9){ref-type="fig"}). The effectiveness of treatment was arbitrarily defined as reported in the paragraph "Effect of H~2~O~2~ on hASCs SA β-Galactosidase activity". We found that the most pronounced effect was detected at 48 h from the end of the treatments: after 1 h of exposure, an increase in the number of positive blue cells could only be observed in the presence of 200 μM H~2~O~2~ (Figure [9](#F9){ref-type="fig"}A), while when cells were treated for 2 h, all H~2~O~2~ concentrations were effective (Figure [9](#F9){ref-type="fig"}B). Based upon these results, SA β-Gal activity was assessed after 48 h from the end of the H~2~O~2~ treatments in hWJ-MSCs harvested from three healthy subjects (at subculture passages 6^th^-9^th^): in Figure [9](#F9){ref-type="fig"}, we also show results from a representative experiment (Figure [9](#F9){ref-type="fig"}C) and the corresponding culture images of H~2~O~2~ 2-h exposure (Figure [9](#F9){ref-type="fig"}D). H~2~O~2~ administration gave an increased percentage of blue cells in comparison with control hWJ-MSCs (Figure [9](#F9){ref-type="fig"}C). This augmentation was dependent upon both the concentration used and the duration of treatment.

Capacity of cells to undergo passages and morphological changes post H~2~O~2~ treatments
----------------------------------------------------------------------------------------

All investigated cell types were able to undergo culture passages post-H~2~O~2~ administration, revealing differences related to H~2~O~2~ concentrations. In fact, while the hMSC growth was found to be slowed down after treatment with H~2~O~2~ 400 μM, and the cells were not further viable on re-plating, cells that had been treated with 100, 150 and 200 μM H~2~O~2~ were still able to undergo at least 2 passages. Furthermore, after increasing H~2~O~2~ concentration and time of exposure, hASCs and hWJ-MSCs changed their morphology at the end of the treatment, at 48 h post treatment and after the re-seeding (Figure [10](#F10){ref-type="fig"} and [11](#F11){ref-type="fig"}). In particular, hASCs become thinner and longer (Figure [10](#F10){ref-type="fig"}), while hWJ-MSCs enlarged and ramified (Figure [11](#F11){ref-type="fig"}).

Effect of H~2~O~2~ on hMSCs gene expression
-------------------------------------------

*p21* and *p53* expression was investigated at 48 h from the end of the H~2~O~2~ specific treatment both in hASCs (*i.e.* 150 µM for 2 h) and hWJ-MSCs (*i.e.* 200 µM for 2 h). As depicted in Figure [12](#F12){ref-type="fig"}, hydrogen peroxide strongly acted on *p21* overexpression in hMSCs independently of their source (p\<0.01). At the same time, H~2~O~2~ treatment in hASCs resulted in a down regulation of *p53* (Figure [12](#F12){ref-type="fig"}A), while in hWJ-MSCs it shows a stable expression in comparison with the control (Figure [12](#F12){ref-type="fig"}B).

Discussion
==========

Both hASCs and hWJ-MSCs are frequently used in stem cell-based protocols [@B2]. These cells undergo significant decline in their rescuing potential as they age *in vivo* during the lifespan, or when they become senescent during their expansion *in vitro*, with significant impairment in the outcome of cell therapy efforts [@B22]-[@B24].

The availability of reliable accelerated methods to induce stem cell senescence *in vitro* will avoid cumbersome long-lasting (2-3 months) culture protocols and facilitate the investigation of senescence mechanisms and source-related senescence susceptibility among different hMSC populations [@B13].

To this end, we observed that hASCs and hWJ-MSCs exhibited different proliferation profiles over time, indicating that basal metabolism may be higher in hWJ-MSCs than in hASCs. Akin to this observation is the present finding that hWJ-MSCs required a greater number of culture passages than hASCs for undergoing senescence, as it can also be inferred from the ability of hWJ-MSCs to exhibit long-lasting stemness properties and preserve a typical fibroblast-like morphology while undergoing multiple culture passages *in vitro* [@B43],[@B74].

Here, we found that in both cell populations, H~2~O~2~ not only inhibited cell proliferation in a dose-dependent fashion, but it also affected the persistence of the anti-proliferative effect after the end of exposure (up to 48 or 72 h) in a manner that was dependent upon the duration (1 or 2 h) of the treatment itself. These results are coherent with the reduction of cell vitality observed in hWJ-MSCs [@B43]-[@B45] and hASCs [@B39],[@B42] treated with higher concentrations of H~2~O~2~ (until 2000 μM) but at low subcultured passages. We also observed a growth slowdown of cells treated with H~2~O~2~ 400 μM, and a cell inability to re-plate. On the other hand, cells treated with 100, 150 and 200 μM H~2~O~2~ were still able to undergo at least 2 passages, although an increase in H~2~O~2~ concentration and exposure time were associated to morphology changes. These results were consistent with those obtained in the study of Choo and coll. (2014), where hWJ-MSCs exposed to H~2~O~2~ resulted enlarged, with cytoplasm enriched of granules and able to undergo until 3-4 passages after H~2~O~2~ treatment [@B43].

The possibility that the observed difference in basal proliferative activity among hASCs and hWJ-MSCs may entail different senescence susceptibilities [@B13],[@B75] was confirmed by the finding that the same H~2~O~2~ concentrations that remarkably inhibited proliferation in hASCs, only weakly affected hWJ-MSC proliferation, and that a significant decrease in the percentage of reduced Resazurin could be achieved in these cells solely after the exposure to the H~2~O~2~ concentration that proved the most effective one in hASCs. Our results are reinforced by the previous evidence that low H~2~O~2~ concentrations (50 and 100 μM) did not affect hWJ-MSCs proliferation treated for 24 h [@B45].

The analysis of the effect of H~2~O~2~ treatment on proliferation in cells that had been subjected to different, even long-term subculture passages (until 14-16^th^), provided the chance of further compounding the multifaceted ways different hMSC populations may progress in senescence. For the first time we demonstrated that H~2~O~2~ given for 2 h, reduced hASC proliferation both in early and late subculture passages, while it decreased hWJ-MSC proliferation in a passage-dependent fashion, in particular only at higher subculture passages.

These observations were all corroborated by results obtained from our analysis of SA β-Gal activity after 24, 48 and 72 h from the end of the H~2~O~2~ treatment, where both hASCs and hWJ-MSCs showed an increase of the SA β-Gal activity. In particular, the higher senescent effect was evident at 48 h. A similar trend was seen in other researches, although it was obtained at different experimental times [@B42]-[@B44].

Comparing SA β-Gal assay results, it is evident that hWJ-MSCs and hASCs have a different way to respond to oxidative stress. To this end, the SA β-Gal activity increase observed in hWJ-MSCs was dependent on both H~2~O~2~ concentration and exposure time, reaching a maximum with 200 μM H~2~O~2~ for 2 h, while hASCs showed the greatest increase with 150 μM H~2~O~2~. In fact, if hASCs were exposed to H~2~O~2~ at low concentrations (*i.e.* 100 μM) they were able to counteract pro-senescence stress, while if cells were treated with 200 μM H~2~O~2~ they showed a SA β-Gal activity increase, although weaker than that induced by 150 μM H~2~O~2~. This observation could be explained by the well documented ability of H~2~O~2~ to promote not only senescence but also apoptosis depending upon the experimental conditions [@B43],[@B76].

The persistence of the hydrogen peroxide effects on cell senescence was shown also by the gene expression analysis of two of the major cell cycle regulators, *p21* and *p53*. At 48 h from the end of the most effective and specific H~2~O~2~ treatment, in both hMSC types the inhibition of cell cycle progression was associated with a strong overexpression of *p21*, a transient growth arrest mediator, able to slowdown cell proliferation [@B22]. At the same time, *p53* transcription was quite stable in hWJ-MSCs, while being down-regulated in hASCs, suggesting that after 2 days from the selected H~2~O~2~ administration, hMSCs did not start an apoptotic program.

Overall the present data not only provide evidence for the effectiveness of the H~2~O~2~ exposure method in recapitulating over time senescence features in hMSCs, but also indicate its usefulness in detecting the proneness of different hMSC populations to undergo senescence on the basis of their tissue source [@B13],[@B73].

In particular, hWJ-MSCs present several advantages comparing with hASCs: not only their easy availability and isolation, their independence from donor age, but also their natural proneness to undergo senescence at late culture passages and their ability to efficiently counteract oxidative stress *stimuli*.

Moreover, within cell therapy contexts, the present study may also set the basis to investigate and establish the limit(s) for *in vitro* expansion of targeted hMSC populations in order to achieve an optimal balance between the cell number available for transplantation and the risk for cell expansion-related senescence. These considerations may also apply to the development of patient-specific protocols for the expansion of defined hMSC populations in the future perspective of Precision Medicine approaches.
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hASCs

:   human Adipose tissue-derived Stem Cells

hWJ-MSCs

:   human Wharton\'s Jelly-derived Mesenchymal Stem Cells

H~2~O~2~

:   hydrogen peroxide

hMSCs

:   human Mesenchymal Stem Cells

SA β-Gal

:   Senescence-Associated β-Galactosidase

ROS

:   Reactive Species of Oxygen

OSIPS

:   Oxidative Stress-Induced Premature Senescence

SOD

:   Superoxide Dismutase

GSH

:   Glutathione Synthetase

*MAPK14*

:   *mitogen-activated protein kinase 14* (alias *p38*)

*SIRT1*

:   *sirtuin 1*

α-MEM

:   alfa-Minimal Essential Medium

DMEM

:   Dulbecco\'s Modified Eagle\'s Medium

FBS

:   Fetal Bovine Serum

*HPRT1*

:   *hypoxanthine phosphoribosyl transferase 1*

*TBP*

:   *TATA box binding protein*

*GAPDH*

:   *glyceraldehyde 3-phosphate dehydrogenase*

*CDKN1A*

:   *cyclin dependent kinase inhibitor 1A* (alias *p21*)

*TP53*

:   *tumor protein p53* (alias *p53*)

p

:   passage

h

:   hour

SD

:   standard deviation

SEM

:   standard error of the mean.

![Comprehensive overview of the experimental procedures.](ijmsv15p1486g001){#F1}

![(A) Cell proliferation and senescence in hASCs and hWJ-MSCs: growth rate of hASCs (n=4) and hWJ-MSCs (n=4) expressed as mean ± standard error of the mean (SEM; \*p\<0.05). Typical hASC and hWJ-MSC morphology at 9^th^ - and 8^th^ culture passages respectively (B), and SA β-Gal staining in hASCs and hWJ-MSCs (C). Cells were analyzed under a light microscope and cell images were detected under bright field illumination with the Leica MC170 HD Imaging System at 200× magnification. Scale bars: 100 μm. Representative blue cells, as markers of senescence, are indicated by black arrows.](ijmsv15p1486g002){#F2}

![Panels A and B: hASCs (A) and hWJ-MSCs (B) cell counts, expressed as growth rates, calculated as the cell number at each time point divided by the cell number of seeded cells. Data are expressed as mean of growth rates ± SD (n=3, \*p\<0.05, \*\*p\<0.01). Panels C and D: percentage of reduction of Resazurin (as indicator of cell proliferation) after treatment of hASCs (C) and hWJ-MSCs (D) for 2 h with H~2~O~2~ (50, 100, 150, 200 or 400 μM). Analysis was conducted on a technical quadruplicate at 4, 24, 48, 72 h (C) or at 2, 24, 48, 72 h (D) from the end of the treatment and data are expressed as mean ± SD.](ijmsv15p1486g003){#F3}

![hASC proliferation curves after treatments with H~2~O~2~ at concentrations of 50 μM (A), 100 μM (B), 150 μM (C) and 200 μM (D) for 1 or 2 h. Analysis was conducted at 4, 24, 48, 72 h from the end of the treatment; data are expressed as mean of percentage of reduction of Resazurin (n=4, culture passages 6^th^- 14^th^) ± SEM, \*p\<0.05, \*\*p\<0.01. CTR is control.](ijmsv15p1486g004){#F4}

![Comparison of cell proliferation between hASCs cultured in the absence (CTR) and presence of H~2~O~2~ at four subculture passages (p6, p9, p11 and p14). Treated cells were incubated with 200 μM H~2~O~2~ for 2 h. Data were expressed as mean of percentage of reduction of Resazurin (technical triplicate) ± SD; \*p\<0.05.](ijmsv15p1486g005){#F5}

![hWJ-MSC proliferation curves after treatment with H~2~O~2~ at concentrations of 50 μM (A), 100 μM (B), 150 μM (C) and 200 μM (D) for 1 or 2 h. Analysis was conducted at 2, 24, 48, 72 h from the end of the treatment; data are expressed as mean of percentage of reduction of Resazurin (n=4, culture passages 6^th^- 16^th^) ± SEM, \*p\<0.05. CTR is control.](ijmsv15p1486g006){#F6}

![Comparison of cell proliferation between hWJ-MSCs cultured in the absence (CTR) and presence of H~2~O~2~ at four subculture passages (p6, p8, p11 and p16). Treated cells were incubated with 200 μM H~2~O~2~ for 2 h. Data were expressed as mean of percentage of reduction of Resazurin (technical triplicate) ± SD; \*p\<0.05.](ijmsv15p1486g007){#F7}

![hASC SA β-Gal activity after H~2~O~2~ treatment. Effect of H~2~O~2~ treatment expressed in term of ratio between the percentage of blue cells in treated sample and the relative percentage of blue cells in untreated sample after 1 h (Panel A) and 2 h (Panel B) of treatment. In each panel the effect of every H~2~O~2~ concentration was presented after 24, 48 and 72 h from the end of the *stimulus*. Data were obtained in triplicate from one subject and expressed as ratio (n=3) ± SD. Control value is 1 (not shown) and treatment was arbitrarily considered effective when ratio was \>3. In Panels (C) and (D) the effects of different H~2~O~2~ concentrations on hASC SA β-Gal activity tested at 48 h from the end of the treatment are shown. In Panel (C), a graph representative of three (obtained from three different subjects) showing the percentage of blue cells in untreated (CTR) and treated cells after 1 and 2 h of H~2~O~2~ treatment. Data were expressed as percentage of blue cells ± SD. Panel (D): representative SA β-Gal staining images of hASCs untreated (CTR) and treated with H~2~O~2~ at final concentrations of 100 μM, 150 μM and 200 μM after 2-h treatment. Cells were analyzed under a light microscope (at 200× magnification) and cell images were detected under bright field illumination with the Leica MC170 HD Imaging System. Blue staining indicates senescent cells and scale bars correspond to 100 μm.](ijmsv15p1486g008){#F8}

![hWJ-MSC SA β-Gal activity after H~2~O~2~ treatment. Effect of H~2~O~2~ treatment expressed in term of ratio between the percentage of blue cells in treated sample and the relative percentage of blue cells in untreated sample after 1 h (Panel A) and 2 h (Panel B) of treatment. In each panel the effect of every H~2~O~2~ concentration was presented after 24, 48 and 72 h from the end of the *stimulus*. Data were obtained in triplicate from one subject and expressed as ratio (n=3) ± SD. Control value is 1 (not shown) and treatment was arbitrarily considered effective when ratio was \>3. In Panels (C) and (D) the effects of different H~2~O~2~ concentrations on hWJ-MSC SA β-Gal activity tested at 48 h from the end of the treatment are shown. In Panel (C), a graph representative of three (obtained from three different subjects) showing the percentage of blue cells in untreated (CTR) and treated cells after 1 and 2 h of H~2~O~2~ treatment. Data were expressed as percentage of blue cells ± SD. Panel (D): representative SA β-Gal staining images of hWJ-MSCs untreated (CTR) and treated with H~2~O~2~ at final concentrations of 100 μM, 150 μM and 200 μM after 2-h treatment. Cells were analyzed under a light microscope (at 200× magnification) and cell images were detected under bright field illumination with the Leica MC170 HD Imaging System. Blue staining indicates senescent cells and scale bars correspond to 100 μm.](ijmsv15p1486g009){#F9}

![Morphological changes of hASCs after reseeding post H~2~O~2~ treatments: control (CTR) cells and cells treated with H~2~O~2~ 100, 150 and 200 μM. Cells were analyzed under a light microscope (at 200× magnification) and cell images were detected under bright field illumination with the Leica MC170 HD Imaging System. Scale bars: 100 μm.](ijmsv15p1486g010){#F10}

![Morphological changes of hWJ-MSCs after reseeding post H~2~O~2~ treatments: control (CTR) cells and cells treated with H~2~O~2~ 100, 150 and 200 μM. Cells were analyzed under a light microscope (at 200× magnification) and cell images were detected under bright field illumination with the Leica MC170 HD Imaging System. Scale bars: 100 μm.](ijmsv15p1486g011){#F11}

![Gene expression analysis in hASCs and hWJ-MSCs after 48 h from 2h-H~2~O~2~ treatment. A: *p21* and *p53* relative expression in hASCs treated with 150 μM H~2~O~2~. B: *p21* and *p53* relative expression in hWJ-MSCs treated with 200 μM H~2~O~2~. Data were expressed as mean fold change (n=3) ± SD, \*\*p\<0.01.](ijmsv15p1486g012){#F12}
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